Medicine News and Research

RSS

BMI or measure of obesity does not play significant role in weight loss operation, says study

A new study investigating why obese patients choose one type of weight loss operation over another reveals that the main factors influencing decision making are whether patients have type 2 diabetes, how much weight they want to lose, and their tolerance for surgical risk to achieve their ideal weight.

25 Nov 2013

SCCA honored as Non-Profit of the Year for providing much-needed service to community

Seattle Cancer Care Alliance and its specialty gift and oncology services store, Shine, were recently recognized by the South Lake Union Chamber of Commerce for their contributions to the community. SCCA was honored as Non-Profit of the Year for offering outstanding benefits and contributions to the community and for providing a much-needed service with a measureable outcome of results. Shine was recognized as Retailer of the Year for being a local South Lake Union retail store that demonstrated excellence in service, products, substantial growth, and community involvement.

25 Nov 2013

Research: Notch protein plays essential role in triggering T-cell development

The lab of Avinash Bhandoola, PhD, professor of Pathology and Laboratory Medicine, has studied the origins of T cells for many years. One protein called Notch, which has well-known roles in the development of multiple tissues, plays an essential role in triggering T-cell development.

25 Nov 2013

Researchers identify immune cell protein that sets off body's initial response against viral infection

A Massachusetts General Hospital-led research team has identified an immune cell protein that is critical to setting off the body's initial response against viral infection. The report that will be published in an upcoming issue of Nature Immunology and is receiving early online release describes finding that a protein called GEF-H1 is essential to the ability of macrophages - major contributors to the innate immune system - to respond to viral infections like influenza.

25 Nov 2013

In health law politics, redistribution is a toxic word

"Redistribution is a loaded word that conjures up all sorts of unfairness in people's minds," said William M. Daley, who was Mr. Obama's chief of staff at the time. Republicans wield it "as a hammer" against Democrats, he said, adding, "It's a word that, in the political world, you just don't use."

25 Nov 2013

Researchers discover how type 2 diabetes drug metformin actually works

Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.

25 Nov 2013

Research roundup: Meeting the needs of assisted living residents; Medicaid expansion and community health centers; money follows the person

Assisted living facilities provide housing and care to persons unable to live independently, and who often have increasing medical needs. Disease outbreaks illustrate challenges of maintaining adequate resident protections in these facilities. ... Of the 50 states, 84% specify health-based admissions criteria to assisted living facilities; 60% require licensed health care professionals to oversee medical care; ... There is wide variation in how assisted living facilities are regulated in the United States.

25 Nov 2013

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.

25 Nov 2013

Researchers identify two gene mutations associated with increased risk of eating disorders

Eating disorders are disturbing and often-heartbreaking ailments that are relatively common, mostly among younger women.

25 Nov 2013

UCSF investigator receives $89 M grant to research on anal cancer in people with HIV

A UC San Francisco investigator has won an eight-year grant from the National Cancer Institute for a major investigation into anal cancer, a debilitating and sometimes fatal disease largely concentrated among people with HIV.

25 Nov 2013

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

A study of 2,519 Kenyan men conducted by researchers at the University of North Carolina revealed that infection with the human papillomavirus (HPV) was associated with a higher subsequent risk of infection with HIV, a precursor to AIDS.

25 Nov 2013

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

23 Nov 2013

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected adults with compensated liver disease, including cirrhosis.

23 Nov 2013

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Bayer HealthCare and Onyx Pharmaceuticals, Inc., an Amgen subsidiary, today announced that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for the oral multi-kinase inhibitor NEXAVAR (sorafenib) tablets for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.

23 Nov 2013

New bill offers hope to HIV patients on transplant waiting lists

A bill scheduled to be signed into law today by President Obama reverses the longtime ban on letting HIV-infected people donate their organs for transplantation after death, a move that offers hope to thousands of HIV patients on transplant waiting lists.

22 Nov 2013

High court's 'alarming' move on abortion; tragic attack in Virginia points to needs in mental health services; a better way to reduce hospital readmissions

In an alarming 5-to-4 ruling, the Supreme Court turned away an emergency application to block a new Texas law that is impeding access to safe and legal abortion care in the state. The ruling leaves in place an order by the United States Court of Appeals for the Fifth Circuit that allowed the law go into effect while it considers an appeal (11/20).

22 Nov 2013

Research report focuses on the impact of real-time cost information within a primary care

Health care costs continue to go up, and physicians control more than 80 percent of those costs. Could providing physicians with real-time information about the cost of what they order help to restrain excessive testing? This is the question addressed in an article- in the Journal of General Internal Medicine-, published by Springer. The research project was led by Daniel Horn of the Massachusetts General Hospital's Division of General Medicine in the US, and is among the first to focus on the impact that the passive display of real-time laboratory costs can have within a primary care, non-academic setting.

22 Nov 2013

First molecular test developed to detect eosinophilic esophagitis

Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.

22 Nov 2013

Scientists hope to find new treatments for traumatic brain injury

In the most wide-reaching project of its kind, scientists at the University of Texas Medical Branch are expanding their research on traumatic brain injury, examining its progressive, chronic effects on the body in hopes of treating its immediate and long-term consequences. The project is funded by a three-year, $9 million grant from The Moody Foundation of Galveston.

22 Nov 2013

New targeted treatments for autism may be possible

Finding major new clues to the origins of autism, a Yale-led team of researchers has pinpointed which cell types and regions of the developing human brain are affected by gene mutations linked to autism. They report their findings in the Nov. 21 issue of the journal Cell.

22 Nov 2013

Medicine News and Research

BMI or measure of obesity does not play significant role in weight loss operation, says study

SCCA honored as Non-Profit of the Year for providing much-needed service to community

Research: Notch protein plays essential role in triggering T-cell development

Researchers identify immune cell protein that sets off body's initial response against viral infection

In health law politics, redistribution is a toxic word

Researchers discover how type 2 diabetes drug metformin actually works

Research roundup: Meeting the needs of assisted living residents; Medicaid expansion and community health centers; money follows the person

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Researchers identify two gene mutations associated with increased risk of eating disorders

UCSF investigator receives $89 M grant to research on anal cancer in people with HIV

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

New bill offers hope to HIV patients on transplant waiting lists

High court's 'alarming' move on abortion; tragic attack in Virginia points to needs in mental health services; a better way to reduce hospital readmissions

Research report focuses on the impact of real-time cost information within a primary care

First molecular test developed to detect eosinophilic esophagitis

Scientists hope to find new treatments for traumatic brain injury

New targeted treatments for autism may be possible

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News